These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17 related articles for article (PubMed ID: 16408268)
1. Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression. He S; Zhang D; Cheng F; Gong F; Guo Y Mol Biol Rep; 2009 Nov; 36(8):2153-63. PubMed ID: 19117119 [TBL] [Abstract][Full Text] [Related]
2. The tyrosine phosphatase HD-PTP is regulated by FGF-2 through proteasome degradation. Mariotti M; Castiglioni S; Beguinot L; Maier JA Front Biosci; 2006 Sep; 11():2138-43. PubMed ID: 16720300 [TBL] [Abstract][Full Text] [Related]
3. The tyrosine phosphatase HD-PTP: A novel player in endothelial migration. Castiglioni S; Maier JA; Mariotti M Biochem Biophys Res Commun; 2007 Dec; 364(3):534-9. PubMed ID: 17959146 [TBL] [Abstract][Full Text] [Related]
4. Differential response to Tat and FGF-2 of two novel clonal populations derived from murine Kaposi-like lesions developing in Tat transgenic mice. Wu Z; Mariotti M; Cavallaro U; Soria MR; Maier JA Microvasc Res; 2002 Jan; 63(1):19-26. PubMed ID: 11749069 [TBL] [Abstract][Full Text] [Related]
6. Fibronectin modulates the effects of HIV-1 Tat on the growth of murine Kaposi's sarcoma-like cells through the down-regulation of tyrosine phosphorylation. Wu Z; Cavallaro U; Marchisio PC; Soria MR; Maier JA Am J Pathol; 1998 Jun; 152(6):1599-605. PubMed ID: 9626063 [TBL] [Abstract][Full Text] [Related]
7. Expression analysis and modulation by HIV-Tat of the tyrosine phosphatase HD-PTP. Mariotti M; Castiglioni S; Maier JA J Cell Biochem; 2006 May; 98(2):301-8. PubMed ID: 16408268 [TBL] [Abstract][Full Text] [Related]
8. Role of ESCRT component HD-PTP/ Gingras MC; Kazan JM; Pause A Biochem Soc Trans; 2017 Jun; 45(3):845-854. PubMed ID: 28620046 [TBL] [Abstract][Full Text] [Related]